Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation.

Autor: Narayanan, Ramesh1 rnarayanan@gtxinc.com, Yepuru, Muralimohan1, Coss, Christopher C.1, Wu, Zhongzhi1, Bauler, Matthew N.1, Barrett, Christina M.1, Mohler, Michael L.1, Wang, Yun1, Kim, Juhyun1, Snyder, Linda M.1, He, Yali1, Levy, Nelson2, Miller, Duane D.1, Dalton, James T.1 jdalton@gtxinc.com
Zdroj: PLoS ONE. Dec2013, Vol. 8 Issue 12, p1-14. 14p.
Databáze: Academic Search Ultimate